Evidence map›Paper›PMID 30018317›Full record

ArticleScientific reports2018

The membrane-associated fraction of cyclase associate protein 1 translocates to the cytosol upon platelet stimulation.

Pooja Joshi, David R J Riley, Jawad S Khalil, Huajiang Xiong, Wei Ji, Francisco Rivero

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Ticagrelor inverse agonist activity at the P2YBritish journal of pharmacology · 2024
    Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Pooja JoshiSchool of Life Science and Technology, Changchun University of Science and Technology, Changchun, Jilin, China.
David R J RileyCentre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Faculty of Health Sciences, University of Hull, Hull, UK.
Jawad S KhalilCentre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Faculty of Health Sciences, University of Hull, Hull, UK.
Huajiang XiongDepartment of Biochemistry, University of Oxford, Oxford, UK.
Wei JiSchool of Life Science and Technology, Changchun University of Science and Technology, Changchun, Jilin, China. jiweicust@163.com.
Francisco RiveroCentre for Atherothrombosis and Metabolic Disease, Hull York Medical School, Faculty of Health Sciences, University of Hull, Hull, UK. francisco.rivero@hyms.ac.uk.ORCID 0000-0001-5435-6991
University of Hull · GBChangchun University of Science and Technology · CNUniversity of Oxford · GB

Funding

British Heart Foundation FS/15/46/31606British Heart Foundation (BHF) FS/15/46/31606
6 · The paper itself

Abstract

Platelets undergo profound shape changes upon adhesion to damaged blood vessel walls that are mediated by reorganisation of the actin cytoskeleton in response to receptor-mediated signalling cascades. The highly conserved 56 kDa multidomain cyclase associated protein 1 (CAP1) works in concert with cofilin and profilin to modulate actin filament turnover by facilitating cofilin-mediated actin filament severing and depolymerisation and catalysing profilin-mediated regeneration of actin monomers for reutilisation in growing filaments. CAP1 is abundant in platelets but its roles remain unexplored. We report that in suspended platelets CAP1 localises predominantly at the cell cortex whereas in spread platelets it is uniformly distributed in the cytoplasm, with enrichment at the cell cortex and the periphery of actin nodules. Upon subcellular fractionation most CAP1 was found cytosolic but part associated to the membrane fraction in an actin-independent manner. Interestingly, upon stimulation with thrombin a significant proportion of the membrane-associated CAP1 translocates to the cytosol. This relocalisation was prevented by prior treatment with PGI2 or the nitric oxide donor GSNO, or by inhibition of GSK3. Our results place CAP1 at a crossroad of signalling pathways that control platelet activation by contributing to actin remodelling at the cell cortex and actin nodules during platelet spreading.

Indexed as

ActinsBlood PlateletsCell Cycle ProteinsCell LineCytoskeletal ProteinsCytosolGlycogen Synthase Kinase 3HumansPlatelet ActivationS-NitrosoglutathioneThrombinActinsCAP1 protein, humanCell Cycle ProteinsCytoskeletal ProteinsGlycogen Synthase Kinase 3S-NitrosoglutathioneThrombin

Identifiers

PMID30018317
PMCPMC6050311
OpenAlexW2866906490

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.